333 related articles for article (PubMed ID: 2983892)
1. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
2. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W
Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
[TBL] [Abstract][Full Text] [Related]
4. Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a Phase III cancer and Leukemia Group B Study.
Maurer LH; Pajak T; Eaton W; Comis R; Chahinian P; Faulkner C; Silberfarb PM; Henderson E; Rege VB; Baldwin PE
J Clin Oncol; 1985 Jul; 3(7):969-76. PubMed ID: 2991478
[TBL] [Abstract][Full Text] [Related]
5. Combined chemotherapy (cisplatin, cyclophosphamide, lomustine and vincristine) and multifractionation radiotherapy in inoperable nonmetastatic squamous cell lung cancer.
Baumöhl J; Jurga L; Klimo J; Jutka K; Zábranská M
Neoplasma; 1992; 39(1):59-63. PubMed ID: 1528305
[TBL] [Abstract][Full Text] [Related]
6. Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung.
Le Chevalier T; Arriagada R; Baldeyrou P; Martin M; Duroux P; Jacquotte A; Sancho-Garnier H; Rouesse J
Cancer Treat Rep; 1985 May; 69(5):469-72. PubMed ID: 4039979
[TBL] [Abstract][Full Text] [Related]
7. Upper hemibody and local chest irradiation as consolidation following response to high-dose induction chemotherapy for small cell bronchogenic carcinoma--a pilot study.
Mason BA; Richter MP; Catalano RB; Creech RB
Cancer Treat Rep; 1982 Aug; 66(8):1609-12. PubMed ID: 6286119
[TBL] [Abstract][Full Text] [Related]
8. [T-activin in the combined treatment of patients with small cell cancer of the lung].
Ausekar BV; Perevodchikova NI; Kadagidze ZG; Derevnina NA; Veskova TK
Vopr Onkol; 1985; 31(4):27-32. PubMed ID: 2988204
[TBL] [Abstract][Full Text] [Related]
9. MACC (methotrexate, doxorubicin, cyclophosphamide and lomustine) versus cis-platinum and etoposide in the treatment of advanced non-small cell lung cancer.
Buccheri G; Ferrigno D; Curcio A; Vola F; Mattalia E
Chemioterapia; 1986 Feb; 5(1):53-7. PubMed ID: 3955784
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin and vinblastine chemotherapy for metastatic non-small cell carcinoma followed by irradiation in patients with regional disease.
Blum RH; Cooper J; Schmidt AM; Ashinoff R; Collins A; Wernz JC; Speyer JL; Boyd A; Muggia FM
Cancer Treat Rep; 1986 Mar; 70(3):333-7. PubMed ID: 3955544
[TBL] [Abstract][Full Text] [Related]
11. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
[TBL] [Abstract][Full Text] [Related]
12. [Inoperable lung epidermoid cancer non metastasizing. A phase II trial using radiotherapy and combined chemotherapy].
Le Chevalier T; Arriagada R; Baldeyrou P; Martin M; Ruffié P; Duroux P; Tarayre M; Rouesse J
Bull Cancer; 1985; 72(1):25-9. PubMed ID: 4039206
[TBL] [Abstract][Full Text] [Related]
13. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
[TBL] [Abstract][Full Text] [Related]
14. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y
Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515
[TBL] [Abstract][Full Text] [Related]
15. Survival analysis of patients with small cell lung cancer.
Serdengeçti S; Büyükünal E; Molinas N; Demirelli FH; Berkarda N; Eyüboğlu H; Derman U; Berkarda B
Chemioterapia; 1988 Apr; 7(2):117-21. PubMed ID: 2840214
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the results of chemotherapy in squamous cell bronchial carcinoma].
Nagorni-Obradović L
Med Pregl; 1991; 44(9-10):387-90. PubMed ID: 1806789
[TBL] [Abstract][Full Text] [Related]
18. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].
Payne DG; Murray N; Warde P
Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117
[TBL] [Abstract][Full Text] [Related]
19. Changes in pulmonary surfactant composition following MACC chemotherapy for lung carcinoma.
Rossi GA; Balbi B; Benatti U; Morelli A; Sacco O; Vassallo F; Ravazzoni C
Eur J Respir Dis; 1987 Nov; 71(5):400-9. PubMed ID: 2832202
[TBL] [Abstract][Full Text] [Related]
20. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
